FDA Helps Makena With Statement Against High-Volume Compounding
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency says it could take enforcement action against pharmacies producing large quantities of the preterm birth drug and physicians should prescribe an approved drug before a compounded version.